Importantly, ibrutinib was found to enhance the cytotoxic effect of DAUN in high p-BTK-expressing AML cells and in the U937 cell line, but not in CD34+ non-malignant cells [75]. The gene discussed is CD34; the disease is acute myeloid leukemia.